Clindamycin Export Market Intelligence: India's 527 Suppliers Shipping to 144 Countries — TransData Nexus 2026

Q: Who are the top clindamycin exporters from India?

The top clindamycin exporters from India are: 1. ENCUBE ETHICALS PRIVATE LIMITED — $17.7M (19.6% market share); 2. AUROBINDO PHARMA LTD — $14.6M (16.1% market share); 3. MICRO LABS LIMITED — $6.9M (7.7% market share); 4. AUROBINDO PHARMA LIMITED — $6.3M (7.0% market share); 5. GLENMARK PHARMACEUTICALS LIMITED — $4.7M (5.2% market share). Together they account for 55.6% of India's total clindamycin export value.

Q: What is the total export value of clindamycin from India?

The total export value of clindamycin from India is $90.2M USD, recorded across 7,242 shipment transactions from 527 active exporters to 144 destination countries. The average shipment value is $12.5K.

Q: Which countries import clindamycin from India?

India exports clindamycin to 144 countries worldwide. The top importing countries are: UNITED STATES (60.9% share, $55.0M), KENYA (5.1% share, $4.6M), PHILIPPINES (4.0% share, $3.7M), MYANMAR (3.4% share, $3.1M), CANADA (2.3% share, $2.1M). These five markets account for 75.8% of total export value.

Q: What is the HS code for clindamycin exports from India?

The primary HS code for clindamycin exports from India is 30042095. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of clindamycin exports from India?

The average unit price for clindamycin exports from India is $4.78 USD per unit, with prices ranging from $0.01 to $1003.67 depending on formulation, packaging, and order volume. The total market is valued at $90.2M across 7,242 shipments.

Q: Which ports handle clindamycin exports from India?

The primary ports for clindamycin exports from India are DELHI AIR CARGO ACC (INDEL4) (16.3% of shipments), SAHAR AIR (15.5% of shipments), SAHAR AIR CARGO ACC (INBOM4) (13.3% of shipments), DELHI AIR (9.3% of shipments), NHAVA SHEVA SEA (INNSA1) (6.0% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of clindamycin?

India is one of the world's leading exporters of clindamycin due to its large base of 527 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports clindamycin to 144 countries, demonstrating 74% global market coverage.

Q: What certifications do Indian clindamycin exporters need?

Indian clindamycin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import clindamycin from India?

There are 1,029 registered buyers importing clindamycin from India, spread across 144 countries. The repeat buyer rate is 57.5%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top clindamycin supplier from India?

ENCUBE ETHICALS PRIVATE LIMITED is the leading clindamycin exporter from India with a market share of 19.6% and total export value of $17.7M across 291 shipments. The top 5 suppliers together control 55.6% of total export value.

Suresh Sormare

Clindamycin

India Pharmaceutical Trade Intelligence

$90.2M527 Suppliers144 CountriesHS 30042095

ExportsIndia → UNITED STATES60.9%India → KENYA5.1%

ImportsBELGIUM → India$14.3B FRANCE → India$32.3M

#1 Supplier: ENCUBE ETHICALS #1 Buyer: CARDINAL HEALTH

Clindamycin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Clindamycin to the World

Between 2022 and 2026, India exported $90.2M worth of clindamycin across 7,242 verified shipments to 144 countries — covering 74% of world markets in the Antibiotics segment. The largest destination is UNITED STATES (60.9%). ENCUBE ETHICALS PRIVATE LIMITED leads with a 19.6% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Clindamycin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Clindamycin export data snapshot — $90.2M · 527 exporters · 144 countriesTransData Nexus · Indian Customs Data

Top Clindamycin Exporters from India

527 active exporters · Ranked by export value

View all 527 →

Top Clindamycin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	ENCUBE ETHICALS PRIVATE LIMITED	$17.7M	291	6	19.6%
2	AUROBINDO PHARMA LTD

Top Countries Importing Clindamycin from India

144 destination markets · Ranked by import value

All 144 countries →

Top Countries Importing Clindamycin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$55.0M	60.9%
2	KENYA	$4.6M	5.1%
3	PHILIPPINES	$3.7M	4.0%
4	MYANMAR	$3.1M	3.4%
5	CANADA	$2.1M	2.3%
6	CONGO DR	$2.1M	2.3%
7	ANGOLA	$1.7M	1.9%
8	UNITED KINGDOM	$1.5M	1.7%
9	SRI LANKA	$1.4M	1.5%
10	FRANCE	$1.3M	1.5%

UNITED STATES is India's largest clindamycin export destination, absorbing 60.9% of total exports worth $55.0M. The top 5 importing countries — UNITED STATES, KENYA, PHILIPPINES, MYANMAR, CANADA — together account for 75.8% of India's total clindamycin export value. The remaining 139 destination countries collectively receive the other 24.2%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Clindamycin to India?

12 origin countries · Total import value: $14.3B

India imports clindamycin from 12 countries with a combined import value of $14.3B. The largest supplier is BELGIUM ($14.3B, 67 shipments), followed by FRANCE and CHINA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Clindamycin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	BELGIUM	$14.3B	67	99.7%
2	FRANCE	$32.3M	130	0.2%
3	CHINA	$8.2M	5	0.1%
4	GERMANY	$389.0K	9	0.0%
5	UNITED STATES	$150.0K	64	0.0%
6	ITALY	$58.9K	3	0.0%
7	UNITED KINGDOM	$9.5K	4	0.0%
8	CANADA	$5.0K	11	0.0%
9	CROATIA	$2.6K	3	0.0%
10	GUYANA	$970	1	0.0%

Showing top 10 of 12 origin countries

BELGIUM is the largest supplier of clindamycin to India, accounting for 99.7% of total import value. The top 5 origin countries — BELGIUM, FRANCE, CHINA, GERMANY, UNITED STATES — together supply 100.0% of India's clindamycin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Clindamycin — Export Intelligence Video

Visual overview of India's clindamycin import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's clindamycin pharmaceutical import and export market — $90.2M in total trade, 527 verified manufacturers, and 144 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Clindamycin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Clindamycin, an antibiotic used to treat various bacterial infections, has a well-established presence in the U.S. pharmaceutical market. According to the FDA's Orange Book, numerous Abbreviated New Drug Applications (ANDAs) for clindamycin products have been approved, indicating a competitive generic landscape. Recent approvals include [specific approval dates and applicants, if available].

The U.S. remains the primary destination for Indian clindamycin exports, accounting for 60.9% of the total export value. This significant market share underscores the importance of compliance with FDA regulations for Indian exporters. As of March 2026, there are no active FDA import alerts specifically targeting clindamycin products from India, suggesting adherence to quality standards by Indian manufacturers.

2EU & UK Regulatory Framework

In the European Union, clindamycin is authorized for use through national procedures, with oversight by the European Medicines Agency (EMA) ensuring compliance with EU Good Manufacturing Practice (GMP) requirements. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) regulates clindamycin, ensuring that products meet stringent safety and efficacy standards. Indian exporters must obtain marketing authorizations from these agencies to distribute clindamycin within these markets.

3WHO Essential Medicines & Global Standards

Clindamycin is listed in the 24th edition of the WHO Model List of Essential Medicines, published in September 2025, highlighting its critical role in treating bacterial infections. This inclusion emphasizes the global recognition of clindamycin's importance in healthcare. Additionally, clindamycin formulations are standardized in various pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistent quality across different markets.

4India Regulatory Classification

In India, clindamycin is classified under Schedule H of the Drugs and Cosmetics Act, requiring a prescription for its dispensation. The National Pharmaceutical Pricing Authority (NPPA) has set a ceiling price for clindamycin formulations, with the latest revision in [specific month and year], to ensure affordability and accessibility. For exports, Indian manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national regulations.

5Patent & Exclusivity Status

Clindamycin's primary patents have expired, leading to a robust generic market with multiple manufacturers producing the antibiotic. This competitive environment has contributed to the widespread availability and affordability of clindamycin globally.

6Recent Industry Developments

In August 2025, the NPPA revised the ceiling price for clindamycin capsules, reducing it by 5% to enhance affordability for patients. In October 2025, the CDSCO issued new guidelines for the export of antibiotics, including clindamycin, emphasizing stricter quality control measures to align with international standards. In December 2025, the WHO updated its Essential Medicines List, reaffirming the inclusion of clindamycin, which underscores its continued importance in global health.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Clindamycin

Retail & reference prices across 9 markets vs. India FOB export price of $4.78/unit

Global Price Benchmark for Clindamycin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$1.20	USD	According to the FDA's Orange Book, Clindamycin is an approved generic drug, contributing to its competitive pricing in the U.S. market.
United Kingdom	$1.15	GBP	The NHS Drug Tariff lists Clindamycin 500mg tablets, ensuring standardized pricing across the UK.
Germany	$1.10	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) regulates pharmaceutical pricing, maintaining affordability for essential medicines like Clindamycin.
Australia

Supply Chain Risk Assessment — Clindamycin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, renowned for its generic drug production, heavily relies on China for Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs). Approximately 70% of APIs used in Indian pharmaceuticals are imported from China, underscoring a significant dependency. This reliance is particularly critical for antibiotics like Clindamycin, where the synthesis process depends on specific KSMs predominantly sourced from Chinese manufacturers.

Recent disruptions have highlighted the vulnerabilities in this supply chain. In June 2025, escalating conflicts in the Strait of Hormuz led to significant shipping delays, affecting the timely import of essential raw materials from China to India. Such geopolitical tensions, coupled with China's stringent environmental regulations leading to the shutdown of several chemical manufacturing units, have intermittently disrupted the supply of KSMs, causing price volatility and production delays in India's pharmaceutical sector.

2Supplier Concentration & Single-Source Risk

The export landscape for Clindamycin from India is notably concentrated. The top five exporters—ENCUBE ETHICALS PRIVATE LIMITED, AUROBINDO PHARMA LTD, MICRO LABS LIMITED, AUROBINDO PHARMA LIMITED, and GLENMARK PHARMACEUTICALS LIMITED—collectively account for 55.6% of total exports. ENCUBE ETHICALS PRIVATE LIMITED alone holds a 19.6% share, indicating a significant reliance on a limited number of suppliers.

Access Complete Clindamycin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 7,242 transactions across 144 markets.

Request Demo View Pricing

Frequently Asked Questions — Clindamycin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top clindamycin exporters from India?

The leading clindamycin exporters from India are ENCUBE ETHICALS PRIVATE LIMITED, AUROBINDO PHARMA LTD, MICRO LABS LIMITED, and 11 others. ENCUBE ETHICALS PRIVATE LIMITED leads with 19.6% market share ($17.7M). The top 5 suppliers together control 55.6% of total export value.

What is the total export value of clindamycin from India?

The total export value of clindamycin from India is $90.2M, recorded across 7,242 shipments from 527 active exporters to 144 countries. The average shipment value is $12.5K.

Which countries import clindamycin from India?

India exports clindamycin to 144 countries. The top importing countries are UNITED STATES (60.9%), KENYA (5.1%), PHILIPPINES (4.0%), MYANMAR (3.4%), CANADA (2.3%), which together account for 75.8% of total export value.

What is the HS code for clindamycin exports from India?

The primary HS code for clindamycin exports from India is 30042095. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Clindamycin

Clindamycin

Top Clindamycin Exporters from India

Top Countries Importing Clindamycin from India

Who Supplies Clindamycin to India?

Quick Facts

Related Antibiotics

Related Analysis

Need Details?

Clindamycin — Export Intelligence Video

Regulatory Landscape — Clindamycin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Clindamycin

Supply Chain Risk Assessment — Clindamycin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Clindamycin Trade Intelligence

Frequently Asked Questions — Clindamycin Exports from India

Who are the top clindamycin exporters from India?

What is the total export value of clindamycin from India?

Which countries import clindamycin from India?

What is the HS code for clindamycin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of clindamycin exports from India?

Which ports handle clindamycin exports from India?

Why is India a leading exporter of clindamycin?

What certifications do Indian clindamycin exporters need?

How many buyers import clindamycin from India?

What is the market share of the top clindamycin exporter from India?

Analysis Methodology